PTCAY:OTC-Chandra Asri Petrochemical Tbk PT ADR (USD)

COMMON STOCK | Specialty Chemicals |

Last Closing

USD 37.45

Change

0.00 (0.00)%

Market Cap

USD 36.50B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
AIQUY Air Liquide SA ADR

+0.08 (+0.20%)

USD 106.43B
AIQUF L'Air Liquide S.A

+0.34 (+0.17%)

USD 105.07B
SKFOF Sika AG

+2.27 (+0.72%)

USD 51.52B
SXYAY Sika AG ADR

+0.10 (+0.32%)

USD 49.25B
GVDBF Givaudan SA

N/A

USD 41.77B
GVDNY Givaudan SA ADR

+1.30 (+1.43%)

USD 41.77B
NVZMY Novozymes AS

+0.65 (+1.04%)

USD 28.08B
NVZMF Novozymes A/S B

+0.09 (+0.15%)

USD 28.08B
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD 19.83B
NPPHY Nippon Paint Holdings Co. Ltd.

+0.39 (+10.80%)

USD 18.23B

ETFs Containing PTCAY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 723.08% 98% N/A 99% N/A
Dividend Return 0.77% 4% F 9% A-
Total Return 723.85% 100% F 99% N/A
Trailing 5 Years  
Capital Gain 277.33% 98% N/A 94% A
Dividend Return 2.29% 7% C- 6% D-
Total Return 279.62% 98% N/A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 61.44% 86% B+ 79% B-
Dividend Return 61.87% 85% B 78% C+
Total Return 0.44% 8% B- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 216.90% 16% F 21% F
Risk Adjusted Return 28.53% 61% D- 64% D
Market Capitalization 36.50B 95% A 97% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector